Elevation Oncology (ELEV) Q2 2025 Earnings

15MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.24
-0.22
-0.2
-0.18

Details

Expected EPS
-0.188
Actual EPS
-0.24
Surprise EPS
-0.05
Surprise Percent
+27.66%

Description

Elevation Oncology (ELEV) has reported earnings of -0.24 per share for Q2 2025.

0 Comments

Share your thoughts